| Follow-up cohort at 3 months (N = 58) |
---|---|
Age, year, median (IQR) | 54 (41–64) |
Male sex, no. (%) | 44 (76) |
Level of education, no. (%) | |
 Primary | 15 (26) |
 Secondary | 24 (41) |
 Tertiary | 19 (33) |
Nicotine abuse, no. (%) | 22 (38) |
Comorbidity, no. (%) | |
 Cardiovascular | 18 (31) |
 Respiratory | 7 (12) |
 Gastrointestinal | 3 (5) |
 Diabetes | 6 (10) |
 Cancer | 8 (14) |
 Immunological | 2 (3) |
 Neurological | 4 (7) |
APACHE II score, median (IQR) | 26 (22–30) |
SAPS III score, median (IQR) | 48 (40–53) |
Sepsis/septic shock (Sepsis 3), no. (%) | 42 (72) |
Mechanical ventilation, no. (%) | 44 (76) |
Delirium, no. (%) | 17 (29) |
Duration of ICU stay, days, median (IQR) | 4.45 (2–8.5) |